Oncologix Tech's Cash & cash equivalent grew by 127.58 % in the Q3 2015 sequentially, faster than Current Liabilities, this led to improvement in Oncologix Tech's Quick Ratio to 0.04, above Oncologix Tech Inc. average Quick Ratio.

Within Medical Equipment & Supplies industry 163 other companies have achieved higher Quick Ratio than Oncologix Tech in third quarter 2015. While Quick Ratio total ranking has improved so far during the Q3 2015 to 4346, from total ranking in the second quarter 2015 at 5195.

Explain Quick Ratio?
How much Cash & cash equivalents OCLG�s has?
What are OCLG�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OCLG Quick Ratio	(May 31 2015) Q3	(Feb 28 2015) Q2	(Nov 30 2014) Q1	(Aug 31 2014) Q4	(May 31 2014) Q3
Y / Y Current Liabilities Change	107.76 %	89.99 %	157.73 %	51.89 %	63.8 %
Y / Y Cash & cash equivalent Change	-17.48 %	-37.94 %	9.14 %	-35.19 %	2314.34 %
Quick Ratio MRQ	0.04	0.02	0.03	0.01	0.11
OCLG's Total Ranking	# 4346	# 5195	# 5287	# 5271	# 4044
Seq. Current Liabilities Change	7.37 %	2.39 %	76.47 %	7.09 %	-1.81 %
Seq. Cash & cash equivalent Change	127.58 %	-23.43 %	254.4 %	-86.64 %	71.15 %

Quick Ratio third quarter 2015 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 164
Healthcare Sector	# 705
Overall Market	# 4346

Quick Ratio Statistics
High	Average	Low
0.11	0.03	0
(May 31 2014)		(Feb 28 2013)

Financial Statements
Oncologix Tech's Current Liabilities	$ 5 Millions	Visit OCLG's Balance sheet
Oncologix Tech's Cash & cash equivalent	$ 0 Millions	Visit OCLG's Balance sheet
Source of OCLG's Sales		Visit OCLG's Sales by Geography

Cumulative Oncologix Tech's Quick Ratio

OCLG's Quick Ratio for the trailling 12 Months

OCLG Quick Ratio	(May 31 2015) 12 Months	(Feb 28 2015) 12 Months	(Nov 30 2014) 12 Months	(Aug 31 2014) 12 Months	(May 31 2014) 12 Months
Y / Y Current Liabilities TTM Growth	101.73 %	92.21 %	113.42 %	103.08 %	169.77 %
Y / Y Cash & cash equivalent TTM Growth	-19.3 %	55.62 %	221.43 %	685.46 %	2833.32 %
Quick Ratio TTM	0.03	0.04	0.05	0.06	0.07
Total Ranking TTM	# 3757	# 3365	# 3943	# 3369	# 3943
Seq. Current Liabilities TTM Growth	18.28 %	18.41 %	30.26 %	10.58 %	12.7 %
Seq. Cash & cash equivalent TTM Growth	-8.87 %	-10.11 %	1.84 %	-3.26 %	75.73 %

Quick ratio ranking by company, industry and sector >> Back to OCLG Financial Strength Comparisons >> Go to Compare OCLG Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2015 to $4.67 millions, cumulative Quick Ratio decreased to 0.03 below the Oncologix Tech Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 130 other companies have achieved higher Quick Ratio than Oncologix Tech. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2015 from 3365 to 3757.

Explain Quick Ratio?
How much Cash & cash equivalents OCLG�s has?
What are OCLG�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 131
Healthcare Sector	# 446
Within the Market	# 3757

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.07	0.03	0
(May 31 2014)		(Feb 29 2012)

Companies with similar Quick Ratio in the quarter ending May 31 2015, within Medical Equipment & Supplies Industry	Quick Ratio	May 31 2015 MRQ Cash & cash equivalent	May 31 2015 MRQ Current Liabilities
Encision Inc	0.10	$ 0.125 Millions	$ 1.195 Millions
Logicmark Inc	0.10	$ 0.154 Millions	$ 1.518 Millions
Micron Solutions Inc	0.09	$ 0.285 Millions	$ 3.199 Millions
Invacare Holdings Corporation	0.09	$ 22.671 Millions	$ 263.659 Millions
Longview Acquisition Corp Ii	0.08	$ 0.003 Millions	$ 0.045 Millions
Alphatec Holdings Inc	0.07	$ 8.898 Millions	$ 122.365 Millions
Remedent Inc	0.06	$ 0.204 Millions	$ 3.286 Millions
Vystar Corporation	0.05	$ 0.039 Millions	$ 0.793 Millions
Infusystem Holdings Inc	0.05	$ 0.791 Millions	$ 16.238 Millions
Fuse Medical Inc	0.05	$ 0.017 Millions	$ 0.371 Millions
Oncologix Tech Inc.	0.04	$ 0.198 Millions	$ 4.665 Millions
Event Cardio Group Inc.	0.04	$ 0.035 Millions	$ 0.865 Millions
Microbot Medical Inc	0.04	$ 0.384 Millions	$ 9.619 Millions
Nu med Plus Inc	0.04	$ 0.011 Millions	$ 0.276 Millions
Odyssey Health Inc	0.03	$ 0.005 Millions	$ 0.164 Millions
The Cooper Companies Inc	0.03	$ 17.005 Millions	$ 529.587 Millions
Positron Corporation	0.03	$ 0.089 Millions	$ 2.970 Millions
Henry Schein Inc	0.03	$ 47.068 Millions	$ 1,636.742 Millions
Non Invasive Monitoring Systems Inc	0.02	$ 0.040 Millions	$ 1.773 Millions
Invo Fertility Inc	0.02	$ 0.080 Millions	$ 4.206 Millions
Sanomedics, Inc.	0.02	$ 0.101 Millions	$ 5.384 Millions
Talkspace Inc	0.02	$ 0.034 Millions	$ 2.035 Millions
Innovage Holding Corp	0.01	$ 0.034 Millions	$ 2.330 Millions
Skinhealth Systems Inc	0.01	$ 0.003 Millions	$ 0.191 Millions
Advanced Biomedical Technologies Inc	0.01	$ 0.059 Millions	$ 4.515 Millions
Zynex inc	0.01	$ 0.087 Millions	$ 7.768 Millions
Yunhong Green Cti Ltd	0.01	$ 0.204 Millions	$ 18.448 Millions

Date modified: 2026-09-08T15:07:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.